Business Development Director
Thomas Daniel-Robin has 12 years of experience in Business Development and Project Management in the Life Sciences sector. He started his career at Genzyme as Business Development Analyst and later on as Project Manager for Genzyme European Cardiovascular Business Unit. Thomas then joined Adhex Pharma, a CDMO specialized in Transdermal and Oromucosal drug delivery, where he was in charge of Business Development and Project Management. Prior to joining Vivet he was Business Development Manager at Genethon.
Thomas holds an Engineering degree from Ecole Nationale Supérieure d’Agronomie de Rennes and a MS in Corporate Finance from ESCP Europe.